Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8957165rdf:typepubmed:Citationlld:pubmed
pubmed-article:8957165lifeskim:mentionsumls-concept:C1832338lld:lifeskim
pubmed-article:8957165lifeskim:mentionsumls-concept:C0494491lld:lifeskim
pubmed-article:8957165lifeskim:mentionsumls-concept:C0180677lld:lifeskim
pubmed-article:8957165lifeskim:mentionsumls-concept:C1413776lld:lifeskim
pubmed-article:8957165lifeskim:mentionsumls-concept:C1420270lld:lifeskim
pubmed-article:8957165lifeskim:mentionsumls-concept:C0013839lld:lifeskim
pubmed-article:8957165lifeskim:mentionsumls-concept:C1153543lld:lifeskim
pubmed-article:8957165lifeskim:mentionsumls-concept:C2346753lld:lifeskim
pubmed-article:8957165lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:8957165lifeskim:mentionsumls-concept:C1707250lld:lifeskim
pubmed-article:8957165lifeskim:mentionsumls-concept:C0547047lld:lifeskim
pubmed-article:8957165lifeskim:mentionsumls-concept:C1177045lld:lifeskim
pubmed-article:8957165pubmed:issue7lld:pubmed
pubmed-article:8957165pubmed:dateCreated1997-3-6lld:pubmed
pubmed-article:8957165pubmed:abstractTextWe retrospectively reviewed electrodiagnostic studies from 1983 to 1994 and found 48 patients who met our criteria for mononeuropathy with axonal loss (40 ulnar, 4 peroneal, 4 radial). Appropriate diagnostic criteria required bilateral studies with a normal contralateral, sensory nerve action potential (SNAP) amplitude decrease of > 50% compared to contralateral, and/or distal compound muscle action potential (CMAP) amplitude decrease of > 40% compared to contralateral, and/or presence of denervation potentials; and sufficient electrodiagnostic investigation to rule out peripheral polyneuropathy. We conclude that in the electrodiagnosis of mononeuropathy with axonal loss: 1) a significant quantitative correlation between CMAP and SNAP amplitude percentage decrease does not exist (r = 0.274, p = 0.06), 2) SNAP amplitude percentage decrease [75.3 +/- 31.8%] is greater than CMAP amplitude percentage decrease [43.9 +/- 31.3%] (paired t-test, p = 0.0001), and 3) CMAP amplitude decrease is positively correlated with the presence of denervation potentials (Xtrend2 = 6.22, p = 0.013).lld:pubmed
pubmed-article:8957165pubmed:languageenglld:pubmed
pubmed-article:8957165pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8957165pubmed:citationSubsetIMlld:pubmed
pubmed-article:8957165pubmed:statusMEDLINElld:pubmed
pubmed-article:8957165pubmed:issn0301-150Xlld:pubmed
pubmed-article:8957165pubmed:authorpubmed-author:DateE SESlld:pubmed
pubmed-article:8957165pubmed:authorpubmed-author:GussnerC GCGlld:pubmed
pubmed-article:8957165pubmed:authorpubmed-author:WuP BPBlld:pubmed
pubmed-article:8957165pubmed:issnTypePrintlld:pubmed
pubmed-article:8957165pubmed:volume36lld:pubmed
pubmed-article:8957165pubmed:ownerNLMlld:pubmed
pubmed-article:8957165pubmed:authorsCompleteYlld:pubmed
pubmed-article:8957165pubmed:pagination405-9lld:pubmed
pubmed-article:8957165pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8957165pubmed:meshHeadingpubmed-meshheading:8957165-...lld:pubmed
pubmed-article:8957165pubmed:meshHeadingpubmed-meshheading:8957165-...lld:pubmed
pubmed-article:8957165pubmed:meshHeadingpubmed-meshheading:8957165-...lld:pubmed
pubmed-article:8957165pubmed:meshHeadingpubmed-meshheading:8957165-...lld:pubmed
pubmed-article:8957165pubmed:meshHeadingpubmed-meshheading:8957165-...lld:pubmed
pubmed-article:8957165pubmed:meshHeadingpubmed-meshheading:8957165-...lld:pubmed
pubmed-article:8957165pubmed:meshHeadingpubmed-meshheading:8957165-...lld:pubmed
pubmed-article:8957165pubmed:meshHeadingpubmed-meshheading:8957165-...lld:pubmed
pubmed-article:8957165pubmed:meshHeadingpubmed-meshheading:8957165-...lld:pubmed
pubmed-article:8957165pubmed:meshHeadingpubmed-meshheading:8957165-...lld:pubmed
pubmed-article:8957165pubmed:meshHeadingpubmed-meshheading:8957165-...lld:pubmed
pubmed-article:8957165pubmed:meshHeadingpubmed-meshheading:8957165-...lld:pubmed
pubmed-article:8957165pubmed:articleTitleCorrelation of EMG, CMAP and SNAP amplitude decrease in mononeuropathies with axonal loss.lld:pubmed
pubmed-article:8957165pubmed:affiliationDepartment of Functional Restoration, Stanford University Medical Center, USA.lld:pubmed
pubmed-article:8957165pubmed:publicationTypeJournal Articlelld:pubmed